NFKB1 and head and neck cancer: Additionally, the interplay between the NF-κB pathway and ER signaling with the Hippo pathway further influences the biological behavior and drug resistance of head and neck cancer, representing a promising breakthrough for future precision therapies (Ma et al., 2021).